Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms
When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater.
New heart device for ‘no-option’ chest pain patients shows early potential
The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.
Women of all ages face rising risks of heart disease and stroke—but cardiologists see a path forward
Cardiovascular disease is already the No. 1 killer among women—and new projections from the American Heart Association suggest things are going to get much worse. There are certain things that clinicians and patients can do, however, to help reverse this trend and save countless lives.
Death after PCI seen in just 0.5% of patients—heart attack, cardiac arrest most common causes
The new analysis included data from more than 22,000 PCI patients treated at one of two high-volume U.S. facilities. Infection was the most common noncardiac cause of death.
CCTA delivers value, even when treating low-risk patients with no history of CAD
Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize.

GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms

When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater.

Image of the A-FLUX Reducer System for chest pain by VahatiCor

New heart device for ‘no-option’ chest pain patients shows early potential

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

Women of all ages face rising risks of heart disease and stroke—but cardiologists see a path forward

Cardiovascular disease is already the No. 1 killer among women—and new projections from the American Heart Association suggest things are going to get much worse. There are certain things that clinicians and patients can do, however, to help reverse this trend and save countless lives.

Death after PCI seen in just 0.5% of patients—heart attack, cardiac arrest most common causes

The new analysis included data from more than 22,000 PCI patients treated at one of two high-volume U.S. facilities. Infection was the most common noncardiac cause of death.

CCTA delivers value, even when treating low-risk patients with no history of CAD

Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize.

iron bioresorbable scaffold Biotyx Medical

Ultrathin iron bioresorbable scaffold shows promise in first randomized trial

An investigational device could help interventional cardiologists avoid the limitations of drug-eluting stents, according to a new analysis published in JACC.

Interventional cardiologists take on angiography-derived physiology in new expert opinion

ADP offers care teams multiple benefits not seen with traditional wire-based physiologic assessments. A roundtable of 17 expert clinicians discussed the topic at length, and their findings were used to develop a new manuscript published in JSCAI.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

Cardiologists should always be involved when heart issues arise after surgery

Cardiac complications after noncardiac surgeries are a significant concern, especially as patients keep living longer and surgical volumes continue to rise.